Dr Robert Finlayson

Dr Robert Finlayson

Adjunct Associate Professor
Medicine & Health
The Kirby Institute

Robert Finlayson has over 30 years clinical experience in HIV and Sexual Health clinical care, research and teaching, and is the Director and Co-founder of Taylor Square Private Clinic. He graduated from the University of Sydney in 1978, became a Fellow of the Australasian College of Sexual Health Physicians in 1990, was elected to Senior Fellowship in 1998 and was formerly NSW state chairman. He is a Founding Fellow of the Australasian Chapter of Sexual Health Medicine within the Royal Australasian College of Physicians.

 

Broad Research Areas

Sexually transmissible infections, human immunodeficiency virus and human papilloma virus infection.

Qualifications

FAChSHM, Sexual Health Medicine
DipVen (Lond)
MB BS (USyd)

Society Memberships & Professional Activities

Senior Fellow of the Australasian College of Sexual Health Physicians
Fellow of the Australasian Chapter of Sexual Health Medicine within the Royal Australasian College of Physicians
Contributor to training program of RACP for Sexual Health Medicine trainees

  • Journal articles | 2024
    Lancaster KE; Stockton M; Remch M; Wester CW; Nash D; Brazier E; Adedimeji A; Finlayson R; Freeman A; Hogan B; Kasozi C; Kwobah EK; Kulzer JL; Merati T; Tine J; Poda A; Succi R; Twizere C; Tlali M; Groote PV; Edelman EJ; Parcesepe AM; IeDEA Consortium , 2024, 'Availability of substance use screening and treatment within HIV clinical sites across seven geographic regions within the IeDEA consortium.', Int J Drug Policy, 124, pp. 104309, http://dx.doi.org/10.1016/j.drugpo.2023.104309
    Journal articles | 2024
    Munari SC; Wilkinson AL; Asselin J; Owen L; Read P; Finlayson R; Martin S; Bell C; O’Connor CC; Carter A; Guy R; McNulty A; Varma R; Chow EPF; Fairley CK; Donovan B; Stoove M; Goller JL; Hocking J; Hellard ME; Aung HL; Dimech W; Apostolellis A; Cogle A; Quinn B; Bradley C; Coase D; Heath-Paynter D; Lewis D; Nolan D; Huddy E; Sanguineti E; Douglas F; Amin J; Davies J; Doumany J; Bastian L; Charleton M; Gunathilake M; Campbell M; Pony M; Alliance S; Roth N; Cunningham P; Rees T; Baillie G; Nguyen T; Polkinghorne V; Traeger M; Watson N, 2024, 'Chlamydia retesting remains low among young women in Australia: an observational study using sentinel surveillance data, 2018–2022', Sexual Health, 21, http://dx.doi.org/10.1071/SH23178
    Journal articles | 2023
    Dharan NJ; Jin F; Vaccher S; Bavinton B; Yeung B; Guy R; Carr A; Zablotska I; Amin J; Read P; Templeton DJ; Ooi C; Martin SJ; Ryder N; Smith DE; McNulty A; Brown K; Price K; Holden J; Grulich AE, 2023, 'Characteristics of Human Immunodeficiency Virus (HIV) Seroconversions in a Large Prospective Implementation Cohort Study of Oral HIV Preexposure Prophylaxis in Men Who Have Sex with Men (EPIC-NSW)', Clinical Infectious Diseases, 76, pp. E622 - E628, http://dx.doi.org/10.1093/cid/ciac660
    Journal articles | 2022
    Bartlett SR; Verich A; Carson J; Hosseini-Hooshyar S; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle JS; Shaw D; Hellard M; Martinez M; Marks P; Dore GJ; Matthews GV; Applegate T; Martinello M; Hosseini Hooshyar S, 2022, 'Patterns and correlates of hepatitis C virus phylogenetic clustering among people living with HIV in Australia in the direct-acting antiviral era: A molecular epidemiology study among participants in the CEASE cohort', Health Science Reports, 5, http://dx.doi.org/10.1002/hsr2.719
    Journal articles | 2022
    Traeger MW; Guy R; Asselin J; Patel P; Carter A; Wright EJ; Grulich A; McManus H; Fairley CK; Chow EPF; McNulty A; Finlayson R; Bell C; Owen L; Marshall L; Russell D; O'Donnell D; Donovan B; Hellard ME; Stoové MA; Bastian L; Bateson D; Bowden S; Boyd M; Callander D; Cogle A; Costello J; Dimech W; Dittmer J; El-Hayek C; Ellard J; Franklin L; Hocking J; Kim J; McGill S; Nolan D; Pendle S; Polkinghorne V; Nguyen L; Nguyen T; O'Connor C; Reed P; Roth N; Ryder N; Selvey C; Vickers T; Walker M; Watchirs-Smith L; West M, 2022, 'Real-world trends in incidence of bacterial sexually transmissible infections among gay and bisexual men using HIV pre-exposure prophylaxis (PrEP) in Australia following nationwide PrEP implementation: an analysis of sentinel surveillance data', The Lancet Infectious Diseases, 22, pp. 1231 - 1241, http://dx.doi.org/10.1016/S1473-3099(22)00175-X
    Journal articles | 2019
    Hey-Nguyen WJ; Bailey M; Xu Y; Suzuki K; Van Bockel D; Finlayson R; Leigh Brown A; Carr A; Cooper DA; Kelleher AD; Koelsch KK; Zaunders JJ, 2019, 'HIV-1 DNA Is Maintained in Antigen-Specific CD4+ T Cell Subsets in Patients on Long-Term Antiretroviral Therapy Regardless of Recurrent Antigen Exposure', AIDS Research and Human Retroviruses, 35, pp. 112 - 120, http://dx.doi.org/10.1089/aid.2018.0235
    Journal articles | 2019
    Hooshyar SH; Martinello M; Yee J; Bartlett S; Read P; Baker D; Post J; Finlayson R; Bloch M; Doyle J; Shaw D; Hellard M; Petoumenos K; Marks P; Applegate T; Dore G; Matthews G, 2019, 'SAT-235-Low HCV reinfection incidence following DAA treatment scale-up in people living with HIV in Australia', Journal of Hepatology, 70, pp. e734 - e734, http://dx.doi.org/10.1016/s0618-8278(19)31468-9
    Journal articles | 2018
    Callander D; Bourne C; Wand H; Stoové M; Hocking JS; De Wit J; Kaldor JM; Donovan B; Pell C; Finlayson R; Baker D; Forssman B; Tee BK; Kefalas B; Duck T; Guy R, 2018, 'Assessing the impacts of integrated decision support software on sexual orientation recording, comprehensive sexual health testing, and detection of infections among gay and bisexual men attending general practice: Observational study', JMIR Medical Informatics, 20, pp. e10808, http://dx.doi.org/10.2196/10808
    Journal articles | 2018
    Grulich AE; Guy R; Amin J; Jin F; Selvey C; Holden J; Schmidt HMA; Zablotska I; Price K; Whittaker B; Chant K; Cooper C; McGill S; Telfer B; Yeung B; Levitt G; Ogilvie EE; Dharan NJ; Hammoud MA; Vaccher S; Watchirs-Smith L; McNulty A; Smith DJ; Allen DM; Baker D; Bloch M; Bopage RI; Brown K; Carr A; Carmody CJ; Collins KL; Finlayson R; Foster R; Jackson EY; Lewis DA; Lusk J; O'Connor CC; Ryder N; Vlahakis E; Read P; Cooper DA; Smith D; Ooi C; Martin S; Soo TM; Templeton D; Townson D; Forssman B; Doong N; Han Thai G; Anderson B; MacLeod H; Parkhill N; Cooper D; Finlayson R; Law M, 2018, 'Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study', The Lancet HIV, 5, pp. e629 - e637, http://dx.doi.org/10.1016/S2352-3018(18)30215-7
    Journal articles | 2017
    Martinello M; Dore GJ; Bopage RI; Finlayson R; Baker D; Bloch M; Filep E; Skurowski J; Lin L; Lamoury F; Bartlett S; Applegate T; Hellard M; Matthews GV, 2017, 'O7 Moving towards HCV elimination in HIV/HCV co- infection in Australia following universal access to interferon-free therapy', Journal of Virus Eradication, 3, pp. 3 - 3, http://dx.doi.org/10.1016/s2055-6640(20)30890-6
    Journal articles | 2017
    Puhr R; Petoumenos K; Youds D; Law MG; Templeton DJ; Ellis D; Bloch M; Agrawal S; Vincent T; Allen D; Smith D; Rankin A; Baker D; O'Connor CC; Thackeray O; Jackson E; McCallum K; Ryder N; Sweeney G; Cooper D; Carr A; Macrae K; Hesse K; Finlayson R; Gupta S; Langton-Lockton J; Shakeshaft J; Brown K; Idle S; Arvela N; Varma R; Lu H; Couldwell D; Eswarappa S; Smith DE; Furner V; Cabrera G; Fernando S; Cogle A; Lawrence C; Mulhall B; Boyd M; Law M; Huang R; Han A; Gunathilake M; Payne R; O'Sullivan M; Croydon A; Russell D; Cashman C; Roberts C; Sowden D; Taing K; Marshall P; Orth D; Rowling D; Latch N; Warzywoda E; Dickson B; Donohue W; Moore R; Edwards S; Boyd S; Roth NJ; Lau H; Read T; Silvers J; Zeng W; Hoy J; Watson K; Bryant M; Price S; Woolley I; Giles M; Korman T; Williams J; Nolan D; Allen A; Guelfi G; Mills G; Wharry C; Raymond N; Bargh K, 2017, 'The impact of changes in HIV management guidelines on time to treatment initiation in Australia', HIV Medicine, 18, pp. 701 - 703, http://dx.doi.org/10.1111/hiv.12504
    Journal articles | 2017
    Smoleń-Dzirba J; Rosińska M; Janiec J; Beniowski M; Cycoń M; Bratosiewicz-Wąsik J; Wasik TJ; Kelleher T; Cooper D; Grey P; Finlayson R; Bloch M; Ramacciotti T; Gelgor L; Smith D; Zangerle R; Gill J; Lutsar I; Chêne G; Dabis F; Thiebaut R; Masquelier B; Costagliola D; Guiguet M; Vanhems P; Chaix ML; Ghosn J; Meyer L; Boufassa F; Hamouda O; Kücherer C; Bartmeyer B; Antoniadou A; Chrysos G; Daikos GL; Touloumi G; Pantazis N; Katsarou O; Rezza G; Dorrucci M; Monforte AD; De Luca A; Prins M; Geskus R; van der Helm J; Schuitemaker H; Sannes M; Brubakk O; Kran AMB; Muga R; Tor J; de Olalla PG; Cayla J; del Amo J; Moreno S; Monge S; del Romero J; Pérez-Hoyos S; Bucher HC; Rickenbach M; Francioli P; Malyuta R; Murphy G; Sabin C; Porter K; Johnson A; Phillips A; Babiker A; Pillay D; Morrison C; Salata R; Mugerwa R; Chipato T; Amornkul PN; Gilmour J; Kamali A; Karita E; Burns F; Giaquinto C; Gibb D; Grarup J; Kirk O; Kjaer J; Panteleev A; Reiss P; Thorne C; Aboulker JP; Albert J; Asandi S; De Wit S; De Wolf F; Gatell J; Karpov I; Ledergerber B; Lundgren J; Møller C; Rakhmanova A; Rockstroh J; Anne AV, 2017, 'HIV-1 infection in persons homozygous for CCR5-Δ32 allele: The next case and the review', AIDS Reviews, 19, pp. 219 - 230
    Journal articles | 2016
    Lee FJ; Monteiro P; Baker D; Bloch M; Roth N; Finlayson R; Moore R; Hoy J; Martinez E; Carr A, 2016, 'Rosuvastatin vs. protease inhibitor switching for hypercholesterolaemia: a randomized trial', HIV Medicine, 17, pp. 605 - 614, http://dx.doi.org/10.1111/hiv.12362
    Journal articles | 2016
    Waters L; Wohl D; Thalme A; Finlayson R; Oka S; Das M; Yau S; Fordyce M, 2016, 'P099 Renal Safety of Tenofovir Alafenamide in Patients at High Risk of Kidney Disease', Sexually Transmitted Infections, 92, pp. A53.2 - A53, http://dx.doi.org/10.1136/sextrans-2016-052718.153
    Journal articles | 2015
    Callander D; Bourne C; Pell C; Finlayson R; Forssman B; Baker D; De Wit J; Hocking J; Stoové M; Donovan B; Kaldor J; Guy R, 2015, 'Recording the sexual orientation of male patients attending general practice', Family Practice, 32, pp. 35 - 40, http://dx.doi.org/10.1093/fampra/cmu061
    Journal articles | 2015
    Chan D; Stewart M; Smith M; Price T; Lusk J; Ooi C; Read P; Finlayson R, 2015, 'The rise of targeted HIV oral rapid testing in Australia', Medical Journal of Australia, 202, pp. 251 - 254, http://dx.doi.org/10.5694/mja14.01292
    Journal articles | 2015
    Han N; Wright ST; O'Connor CC; Hoy J; Ponnampalavanar S; Grotowski M; Zhao HX; Kamarulzaman A; Ellis D; Bloch M; Franic T; Agrawal S; McCann L; Cunningham N; Vincent T; Allen D; Little JL; Smith D; Gray C; Baker D; Vale R; Templeton DJ; Dijanosic C; Jackson E; McCallum K; Taylor S; Cooper D; Carr A; Lee F; Hesse K; Sinn K; Norris R; Finlayson R; Prone I; Shakeshaft J; Brown K; McGrath C; McGrath V; Halligan S; Wray L; Read P; Lu H; Couldwell D; Furner V; Watson J; Lawrence C; Mulhall B; Law M; Petoumenos K; McManus H; Bendall C; Boyd M; Kulatunga A; Knibbs P; Chuah J; Ngieng M; Dickson B; Russell D; Downing S; Sowden D; Broom J; Taing K; Johnston C; McGill K; Orth D; Youds D; Kelly M; Gibson A; Magon H; Donohue W; Moore R; Edwards S; Liddle R; Locke P; Roth NJ; Nicolson J; Lau H; Read T; Silvers J; Zeng W; Watson K; Bryant M; Price S; Woolley I; Giles M; Korman T; Williams J; Nolan D; Skett J; Robinson J; Mean CV; Saphonn V; Vohith K; Zhang FJ; Li PCK; Lee MP; Kumarasamy N; Saghayam S; Ezhilarasi C; Pujari S, 2015, 'HIV and aging: Insights from the Asia Pacific HIV Observational Database (APHOD)', HIV Medicine, 16, pp. 152 - 160, http://dx.doi.org/10.1111/hiv.12188
    Journal articles | 2015
    Mocroft A; Lundgren JD; Ross M; Law M; Reiss P; Kirk O; Smith C; Wentworth D; Neuhaus J; Fux CA; Moranne O; Morlat P; Johnson MA; Ryom L; Powderly B; Shortman N; Moecklinghoff C; Reilly G; Franquet X; Sabin CA; Phillips A; Weber R; Pradier C; d'Arminio Monforte A; Dabis F; El-Sadr WM; De Wit S; Kamara D; Tverland J; Mansfeld M; Nielsen J; Raben D; Salbøl Brandt R; Rickenbach M; Fanti I; Krum E; Hillebregt M; Geffard S; Sundström A; Delforge M; Fontas E; Torres F; McManus H; Wright S; Kjær J; Sjøl A; Meidahl P; Helweg-Larsen J; Schmidt Iversen J; Kesselring AM; Friis-Møller N; Kowalska J; Sabin C; Bruyand M; Kamara DA; Bower M; Fätkenheuer G; Donald A; Grulich A; Prins JM; Kuijpers TW; Scherpbier HJ; van der Meer JTM; Wit FWMN; Godfried MH; van der Poll T; Nellen FJB; Geerlings SE; van Vugt M; Pajkrt D; Bos JC; Wiersinga WJ; van der Valk M; Goorhuis A; Hovius JW; van Eden J; Henderiks A; van Hes AMH; Mutschelknauss M; Nobel HE; Pijnappel FJJ; Westerman AM; Jurriaans S; Back NKT; Zaaijer HL; Berkhout B; Cornelissen MTE; Schinkel CJ; Thomas XV; van den Berge M; Stegeman A; Baas S; Hage de Looff L; Versteeg D; Pronk MJH; Ammerlaan HSM; Korsten-Vorstermans EMHM; de Munnik ES; Jansz AR; Tjhie J; Finlayson R; Cooper D; Carr A; Bloch M; Harrod M; Pett S; Petoumenos K; Gold J; Medland N; Sullivan J; Han A, 2015, 'Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study', PLoS Medicine, 12, pp. e1001809, http://dx.doi.org/10.1371/journal.pmed.1001809
    Journal articles | 2015
    Petoumenos K; Watson J; Whittaker B; Hoy J; Smith D; Bastian L; Finlayson R; Sloane A; Wright ST; McManus H; Law MG; Han A, 2015, 'Subsidized optimal ART for HIV-positive temporary residents of Australia improves virological outcomes: Results from the Australian HIV Observational Database Temporary Residents Access Study', Journal of the International AIDS Society, 18, pp. 19392, http://dx.doi.org/10.7448/IAS.18.1.19392
    Journal articles | 2014
    Fernandez CS; Kelleher AD; Finlayson R; Godfrey DI; Kent SJ, 2014, 'NKT cell depletion in humans during early HIV infection', Immunology and Cell Biology, 92, pp. 578 - 590, http://dx.doi.org/10.1038/icb.2014.25
    Journal articles | 2013
    Matthews G; Seaberg E; Avihingsanon A; Bowden S; Dore GJ; Lewin SR; Sasadeusz JJ; Revill PA; Littlejohn M; Hoy J; Finlayson R; Ruxrungtham K; Saulynas M; Locarnini S; Thio C, 2013, 'Patterns and causes of suboptimal response to tenofovir-based therapy in individuals coinfected with HIV and hepatitis B virus', Clinical Infectious Diseases, 56, pp. e87 - e94, http://dx.doi.org/10.1093/cid/cit002
    Journal articles | 2013
    Seddiki N; Phetsouphanh C; Swaminathan S; Xu Y; Rao S; Li J; Sutcliffe E; Denyer G; Finlayson R; Gelgor L; Cooper DA; Zaunders J; Kelleher AD, 2013, 'The microRNA-9/B-lymphocyte-induced maturation protein-1/IL-2 axis is differentially regulated in progressive HIV infection', European Journal of Immunology, 43, pp. 510 - 520, http://dx.doi.org/10.1002/eji.201242695
    Journal articles | 2012
    Haskelberg H; Hoy J; Amin J; Ebeling PR; Emery S; Carr AD, 2012, 'Changes in Bone Turnover and Bone Loss in HIV-Infected Patients Changing Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine', PLoS ONE, 7, pp. e38377, http://dx.doi.org/10.1371/journal.pone.0038377
    Journal articles | 2012
    Koelsch KK, 2012, 'No significant effect of uridine or pravastatin treatment for HIV lip atrophy in men who have ceased thymidine analogue nucleoside reverse transcriptase inhibitor therapy: a randomised trial.', HIV Medicine, 11, pp. 493 - 501
    Journal articles | 2012
    Shields M; Guy RJ; Jeoffreys NJ; Finlayson R; Donovan B, 2012, 'A longitudinal evaluation of Treponema pallidum PCR testing in early syphilis', BMC Infectious Diseases, 12, pp. Article number353, http://dx.doi.org/10.1186/1471-2334-12-353
    Journal articles | 2011
    Audsley J; Seaberg E; Sasadcusz J; Matthews G; Avihingsanon A; Ruxrungtham K; Fairley K; Finlayson RJ; Hwang H; Littlejohn M; Locarnini S; Dore GJ; Thio C; Lewin S, 2011, 'Factors associated with elevated ALT in an international HIV/HBV Co-Infected cohort on long-term HAART', PLoS One, 6, pp. e26482, http://dx.doi.org/10.1371/journal.pone.0026482
    Journal articles | 2008
    Kim M; Taylor J; Sidney J; Mikloska Z; Bodsworth N; Lagios K; Dunckley H; Byth-Wilson K; Denis M; Finlayson R; Khanna R; Sette A; Cunningham AL, 2008, 'Immunodominant epitopes in herpes simplex virus type 2 glycoprotein D are recognized by CD4 lymphocytes from both HSV-1 and HSV-2 seropositive subjects', Journal of Immunology, 181, pp. 6604 - 6615, http://dx.doi.org/10.4049/jimmunol.181.9.6604
    Journal articles | 2007
    Barbour T; Furlong TJ; Finlayson RJ, 2007, 'Efavirenz-associated podocyte damage', AIDS, 21, pp. 257 - 258
    Journal articles | 2006
    Bloch MT; Smith DE; Quan D; Kaldor JM; Zaunders J; Petoumenos K; Irvine K; Law MG; Grey PA; Finlayson R; Mcfarlane R; Kelleher AD; Carr AD; Cooper DA, 2006, 'The role of hydroxyurea in enhancing the virologic control achieved through structured treatment interruption in primary HIV infection: Final results from a randomized clinical trial (Pulse)', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 42, pp. 192 - 202
    Journal articles | 2006
    Pett SL; Wand HC; Law MG; Arduino R; Lopez JC; Knysz B; Pereira L; Pollack S; Reiss P; Tambussi G, 2006, 'Evaluation of subcutaneous proleukin (interleukin-2) in a randomized international trial (ESPRIT): Geographical and gender differences in the baseline characteristics of participants', HIV Clinical Trials, 7, pp. 70 - 85
    Journal articles | 2005
    Petoumenos K; Ringland C, 2005, 'Antiretroviral treatment change among HIV, hepatitis B virus and hepatitis C virus co-infected patients in the Australian HIV Observational Database', HIV Medicine, 6, pp. 155 - 163
    Journal articles | 2005
    Zaunders J; Munier M; Kaufmann D; Ip S; Grey PA; Smith DE; Ramacciotti TP; Quan D; Finlayson RJ; Kaldor JM; Rosenberg E; Walker BD; Cooper DA; Kelleher AD, 2005, 'Early proliferation of CCR5(+) CD38(+++) antigen-specific CD4(+) Th1 effector cells during primary HIV-1 infection', Blood, 106, pp. 1660 - 1667
    Journal articles | 2004
    Ledergerber B; Lundgren JD; Sarah Walker A; Sabin C; Justice A; Reiss P; Mussini C; Wit F; d'Arminio Monforte A; Weber R; Fusco G; Staszewski S; Law M; Hogg R; Lampe F; John Gill M; Castelli F; Phillips AN; Rooney P; Taylor S; Couldwell D; Austin D; Block M; Clemons J; Finlayson R; Petoumenos K; Quan D; Smith D; O'Connor C; Gorton C; Allen D; Mulhall B; Mutimer K; Keeffe N; Cooper D; Carr A; Miller J; Pell C; Ellis D; Baker D; Kidd J; McFarlane R; Liang MT; Brown K; Huffam S; Savage J; Morgan S; Knibbs P; Sowden D; Walker A; Orth D; Lister G; Chuah J; Fankhauser W; Dickson B; Bradford D; Wilson C; Ree H; Magon H; Anderson J; Moore R; Russell D; McGovern G; McNair R; Bal J; Fairley K; Roth N; Eu B; Strecker S; Wood H; Mijch A; Hoy J; Pierce A; McCormack C; Watson K; Medland N; Daye J; Mallal S; French M; Skett J; Maxwel D; Cain A; Montroni M; Scalise G; Costantini A; Giacometti A; Tirelli U; Nasti G; Pastore G; Ladisa N; Perulli ML; Suter F; Arici C; Maggiolo F; Chiodo F; Gritti FM; Colangeli V; Fiorini C; Guerra L; Carosi G, 2004, 'Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes', Lancet, 364, pp. 51 - 62, http://dx.doi.org/10.1016/S0140-6736(04)16589-6
    Journal articles | 2004
    Martin A; Smith DE; Carr AD; Hoy JF; Chuah J; Mallal SA; Law MG; Clements MS; Cooper DA, 2004, 'Progression of lipodystrophy (LD) with continued thymidine analogue usage: Long-term follow-up from a randomized clinical trial (the PIILR study)', HIV Clinical Trials, 5, pp. 192 - 200, http://thomasland.metapress.com/content/0gu76x27mmhe5ale/
    Journal articles | 2003
    Lincoln DW; Petoumenos K; Dore GJ, 2003, 'HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy', HIV Medicine, 4, pp. 241 - 249
    Journal articles | 2002
    Baker D; Law MG; Petoumenos K; Smith DE; Anderson JA; Roth N; Mallal SA, 2002, 'Rates of combination antiretroviral treatment change in Australia, 1997-2000', HIV Medicine, 3, pp. 28 - 36
    Journal articles | 2002
    Kaufmann GR; Bloch MT; Finlayson RJ; Zaunders J; Smith DE; Cooper DA, 2002, 'The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapy', AIDS, 16, pp. 359 - 367
    Journal articles | 2001
    Carr AD; Baker D; Petoumenos K; Law MG; Smith D; Roth N; Anderson JA; Mallal SS, 2001, 'Time trends in antiretroviral treatment use in Australia', Venereology - the Interdisciplinary International Journal of Sexual Health, 14, pp. 162 - 168
    Journal articles | 2001
    Suzuki K; Cunningham P; Harris C; Leas L; Zaunders J; Cooper DA; Kaufmann GR; Pett SL; Kelleher A; Mukaide M; Imai M; Kondo M; Finlayson R, 2001, 'Novel deletion of HIV type 1 reverse transcriptase residue 69 conferring selective high-level resistance to nevirapine', AIDS Research and Human Retroviruses, 17, pp. 1293 - 1296, http://dx.doi.org/10.1089/088922201750461366
    Journal articles | 1998
    Grulich A; Wan X; Law M; Milliken S; Lewis C; Garsia R; Gold J; Finlayson R; Cooper DA; Kaldor JM, 1998, 'RISK FACTORS FOR AIDS ASSOCIATED NON-HODGKIN'S LYMPHOMA: A CASE-CONTROL STUDY.', Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 17, pp. A39 - A39, http://dx.doi.org/10.1097/00042560-199804010-00127
    Journal articles | 1997
    Stewart GA; Ashton LJ; Biti RA; Ffrench FA; Bennetts BH; Newcombe NR; Benson EM; Carr AD; Cooper DA; Kaldor JM; Smith DD; Catchpole BR; Allworth A; Baker D; Batty G; Beveridge A; Bloch M; Bodsworth NJ; Clare K; Cummins E; Cunningham PH; Couldwell D; Deacon N; Doong N; Finlayson R; Furner V; Huffam SE; Kidd J; Kelly MD; Lloyd AR; Mcfarlane R; Mclean K; Mcnulty A; Mcphee D; Michelmore H; Mcmurchie M; Mutimer K; Peterson J; Price R; Quan J; Qurn J; Ree H; Robertson M; Roggensack M; Schroeder K; Spencer D; Sullivan JS; Ziegler JB, 1997, 'Increased frequency of CCR-5 delta32 heterozygotes among long-term nonprogressors with HIV infection.', AIDS, 11, pp. 1833 - 1838
    Journal articles | 1990
    Donovan B; Finlayson RJ; Mutimer K; Price R; Robertson M; Nelson M; Slade M; Reece I; Nogare JD, 1990, 'HIV infection in sexually transmissible disease practice in sydney: The effects of legislation, public education and changing clinical spectrum', International Journal of STD and AIDS, 1, pp. 21 - 27, http://dx.doi.org/10.1177/095646249000100106
    Journal articles | 1990
    Donovan B; Tindall B; Barnes T; Bodsworth N; Cunningham AL; Finlayson R; Price R; Robertson M; Wodak A; Ziegler JB; Cooper DA, 1990, 'If I have sex with a duck does that make me a drake? The Albion Street (AIDS) Centre, intravenous drug use and 'prostitution' (I)', Medical Journal of Australia, 152, pp. 497 - 498
    Journal articles | 1989
    Tindall B; Finlayson R; Mutimer K; Billson FA; Munro VF; Cooper DA, 1989, 'Malignant melanoma associated with human immunodeficiency virus infection in three homosexual men', Journal of the American Academy of Dermatology, 20, pp. 587 - 591, http://dx.doi.org/10.1016/S0190-9622(89)70068-2
    Journal articles | 1985
    Cooper DA; Maclean P; Finlayson R; Michelmore HM; Gold J; Donovan B; Barnes TG; Brooke P; Penny R, 1985, 'ACUTE AIDS RETROVIRUS INFECTION. Definition of a Clinical Illness Associated with Seroconversion', The Lancet, 325, pp. 537 - 540, http://dx.doi.org/10.1016/S0140-6736(85)91205-X
    Journal articles | 1982
    Donovan B; Finlayson R; Mutimer K; Millin G, 1982, 'Genital and anorectal warts: What treatment?', Current Therapeutics, 23, pp. 29 - 32
  • Conference Posters | 2019
    Carr M; Martin SJ; Foster R; Finlayson R; Rule J; Smith DE; de Wit J; Carr A; Siefried KJ, 2019, 'STI incidence and risk factors in HIV-infected adults on antiretrovrial therapy (ART) in the PAART study', Perth, Australia, presented at Joint Australasian Sexual Health and HIV&AIDS Conference, Perth, Australia, 16 September 2019 - 19 September 2019
    Conference Abstracts | 2018
    Martinello M; Bartlett S; Dore G; Bopage R; Finlayson R; Baker D; Bloch M; Doyle J; Shaw D; Hajkowicz K; Read P; Filep E; Lin L; Yee J; Applegate T; Hellard M; Matthews G, 2018, 'Universal access to DAA therapy paves the way for HCV control and elimination among people living with HIV in Australia', in Universal access to DAA therapy paves the way for HCV control and elimination among people living with HIV in Australia, Paris, France, presented at THE INTERNATIONAL LIVER CONGRESS 2018, Paris, France, 11 April 2018 - 15 April 2018
    Conference Abstracts | 2017
    Martinello M; Dore GJ; Bopage RI; Finlayson R; Baker D; Bloch M; Wilcox A; Filep E; Hellard M; Matthews GV, 2017, 'DAA treatment scale-up in HIV/HCV co-infection: characterisinga population at risk for reinfection', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, Vol. 66, pp. S495 - S496, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)31388-0
    Conference Posters | 2014
    Callander DJ; Bourne C; Finlayson R; Pell C; Baker D; Gowers A; Tee B; Stoové M; Donovan B; Katon L; de Wit J; Kaldor J; Guy R, 2014, 'High rates of delays HIV diagnosis among men how have sex with men attending primary care suggests the need for health promotion strategies', Melbourne, Australia, presented at World AIDS Conference, Melbourne, Australia, 21 July 2014 - 25 July 2014, http://static.squarespace.com/static/515fabbee4b0d5cb924aa602/t/53c5c997e4b01886bc5514e1/1405471127819/AIDS%202014%20poster%2016Ju14.pdf
    Conference Papers | 2010
    Audsley J; Seaberg E; Sasadeusz J; Matthews GV; Avihingsanon A; Ruxrungtham K; Fairley K; Finlayson R; Hwang HS; Littlejohn M; Dore GJ; Locarnini S; Thio CL; Lewin SR, 2010, 'Factors associated with elevated ALT in an international HIV/HBV co-infected cohort on long-term HAART', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, ENGLAND, London, pp. A53 - A53, presented at 12th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, ENGLAND, London, 04 November 2010 - 06 November 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000287431200068&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2010
    Audsley J; Seaberg E; Sasadeusz J; Matthews GV; Avihingsanon A; Ruxrungtham K; Fairley K; Finlayson R; Hwang HS; Littlejohn M; Dore GJ; Locarnini S; Thio CL; Lewin SR, 2010, 'Factors associated with elevated ALT in an international HIV/HBV co-infected cohort on long-term HAART', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, ENGLAND, London, pp. A53 - A53, presented at 12th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, ENGLAND, London, 04 November 2010 - 06 November 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000287431500054&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Preprints |
    Martinello M; Yee J; Bartlett SR; Read P; Baker D; Post J; Finlayson R; Bloch M; Doyle J; Shaw D; Rowling D; Doong N; Jackson E; Hellard M; Petoumenos K; Lin L; Marks P; Applegate T; Dore GJ; Matthews GV, Moving Towards HCV Elimination Among People Living with HIV in Australia: Analysis of the CEASE Prospective Cohort Study, http://dx.doi.org/10.2139/ssrn.3269607